PharmiWeb Today Story
World Tumor Registry has launched its Breast Cancer Registry, an open access digital platform designed to support more accurate breast cancer diagnosis worldwide. The new resource brings together expert reviewed tumour cases, including both common and rare forms, and allows users to study high quality whole slide images alongside clinical, biomarker and molecular information. Led by Dr Edi Brogi of Memorial Sloan Kettering Cancer Center, the project already includes 100 fully annotated cases, with a target of 500 by year end.
The organisation says the registry is intended to help pathologists and trainees around the world learn from a broader range of cases and improve diagnostic confidence. World Tumor Registry also plans to expand further with lung, skin and melanoma registries later this year, as part of a wider effort to build a comprehensive global educational cancer resource.
Read More...
Articles
Featured Events
-
Pharma USA 2022
16-Mar-2022 - 17-Mar-2022 -
Reuters Events: Pharma 2022
11-Oct-2022 - 13-Oct-2022 -
Reuters Events: Pharma USA 2023
28-Mar-2023 - 29-Mar-2023 -
The Pharmaceutical Manufacturing and Packaging Con…
12-Jun-2023 - 13-Jun-2023 -
PharmaMarketing USA Summit
08-Feb-2024 - 09-Feb-2024 -
PM Society: Pharmaceutical Marketing for Non-Marke…
27-Feb-2024 - 29-Feb-2024
News
-
Freya Biosciences announces positive Phase 1 first…
16-Apr-2026 -
Faron Announces Collaboration with Parexel to Supp…
16-Apr-2026 -
Theis Kipling to Assume Role as CEO of Biovica on…
16-Apr-2026 -
GNQ Insilico Plans to Accelerate Precision Medicin…
16-Apr-2026 -
Enodia Therapeutics nomme la Dre Yvonne McGrath au…
16-Apr-2026 -
Bayer Canada Supports New School of Medicine at Si…
15-Apr-2026